Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fludrocortisone 750micrograms/5ml oral suspension
0603010I0AABIBI
|
Fludrocort acetate | Fludrocortisone acetate | Endocrine System | No data available |
|
Fludrocortisone 75micrograms/5ml oral suspension
0603010I0AAA7A7
|
Fludrocort acetate | Fludrocortisone acetate | Endocrine System | No data available |
|
Fludrocortisone 850micrograms/5ml oral suspension
0603010I0AABGBG
|
Fludrocort acetate | Fludrocortisone acetate | Endocrine System | No data available |
|
Fludrocortisone 85micrograms/5ml oral suspension
0603010I0AABTBT
|
Fludrocort acetate | Fludrocortisone acetate | Endocrine System | No data available |
|
Fluenz (trivalent) vaccine nasal suspension 0.2ml unit dose
1404000H0CFAAAS
|
Fluenz (trivalent) | Influenza | Immunological Products and Vaccines | No data available |
|
Fluenz vaccine nasal suspension 0.2ml unit dose
1404000H0BRAAAJ
|
Fluenz | Influenza | Immunological Products and Vaccines | No data available |
|
Fluimucil 600 effervescent tablets
0307000C0BDAFAJ
|
Fluimucil | Acetylcysteine | Respiratory System | No data available |
|
Fluimucil N 100mg granules sachets
0307000C0BDAEAL
|
Fluimucil | Acetylcysteine | Respiratory System | No data available |
|
Fluimucil N 200mg granules sachets
0307000C0BDAAAA
|
Fluimucil | Acetylcysteine | Respiratory System | No data available |
|
Flumazenil 500micrograms/5ml solution for injection ampoules
1501070F0AAAAAA
|
Flumazenil | Flumazenil | Anaesthesia | No data available |
|
FluMist Quadrivalent vacc nsl susp 0.2ml unit dose
1404000H0BVAAAJ
|
FluMist Quadrivalent | Influenza | Immunological Products and Vaccines | No data available |
|
Flunarizine 20mg tablets
0406000E0AAAEAE
|
Flunarizine dihydrochloride | Flunarizine dihydrochloride | Central Nervous System | No data available |
|
Flunitrazepam 1mg tablets
0401010I0AAAAAA
|
Flunitrazepam | Flunitrazepam | Central Nervous System | No data available |
|
Fluocinolone acetonide 0.025% / Neomycin 0.5% cream
1304000N0AACBCB
|
Fluocinolone acetonide | Fluocinolone acetonide | Skin | No data available |
|
Fluocinonide 0.05% ointment 10% in Emulsifying ointment
1304000P0AABJBJ
|
Fluocinonide | Fluocinonide | Skin | No data available |
|
Fluocinonide 0.05% ointment 10% in White soft paraffin
1304000P0AABHBH
|
Fluocinonide | Fluocinonide | Skin | No data available |
|
Fluocinonide 0.05% ointment 25% in White soft paraffin
1304000P0AABGBG
|
Fluocinonide | Fluocinonide | Skin | No data available |
|
Fluocinonide 0.05% ointment 25% in Yellow soft paraffin
1304000P0AABLBL
|
Fluocinonide | Fluocinonide | Skin | No data available |
|
Fluocinonide 0.05% ointment 30% in Emulsifying ointment
1304000P0AABKBK
|
Fluocinonide | Fluocinonide | Skin | No data available |
|
Fluocinonide 0.05% ointment 50% in White soft paraffin
1304000P0AABFBF
|
Fluocinonide | Fluocinonide | Skin | No data available |
|
Fluocortolone 0.25% / Fluocortolone hexanoate 0.25% ointment
1304000R0AABBBB
|
Fluocortolone | Fluocortolone | Skin | No data available |
|
Fluocortolone hexan 0.25%/Fluocortolone pival 0.25% crm
1304000R0AAABAB
|
Fluocortolone | Fluocortolone | Skin | No data available |
|
Fluor-a-day 2.2mg chewable tablets
0905030G0BMAABT
|
Fluor-a-day | Sodium fluoride | Nutrition and Blood | No data available |
|
Fluorescein 1mg ophthalmic strips
1108020K0AAAEAE
|
Fluorescein sodium | Fluorescein sodium | Eye | No data available |
|
Fluorets 1mg ophthalmic strips
1108020K0BEAAAE
|
Fluorets | Fluorescein sodium | Eye | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.